CSI Market
Sign In | Register

International Stem Cell (ISCO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ISCO quarterly Cash Flow →
The data below summarizes International Stem Cell's cash flow activity from Dec 31 2021 to Dec 31 2025, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-0.42
Depreciation & amortization0.22
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Impairment of Intangible Assets, Finite-lived0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.39
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation0.29
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Accretion Of Discount On Notes Payable-
Accretion Of Discount On Bridge Loans-
Non Cash Warrants For Services-
Non Cash Compensation Expense-
Change In Market Value Of Warrants-
Fair Value Of Warrant Liabilities In Excess Of Proceeds-
Financial Services Costs-
Change In Inventory Obsolescence-
Warrant Modification Expense-
Allowance For Loan And Lease Loss Recovery Of Bad Debts-
Inventory Adjustment-
Non Cash Operating Lease Expense0.31
Increase Decrease In Operating Lease Liabilities-0.35
Interest Expense Related Party-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.34
Increase (Decrease) in Accounts Payable-0.02
Increase (Decrease) in Accrued Liabilities-0.10
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.06
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.19
Discontinued operations0.00
Net Cash flow from Operating Activities0.01
Investing Activities
Capital Expenditures-0.05
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.05
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.20
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Increase (Decrease) in Deposits Outstanding0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Convertible Promissory Notes-
Proceeds From Exercise Of Options And Warrants-
Payment Of Promissory Notes-
Proceeds From Bridge Loan From Related Party-
Payments On Financed Insurance Premiums-
Proceeds From Paycheck Protection Program Loan Amount-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.20
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.04
Total Cash Flow-0.24
4 historic quarters locked

Sign in to unlock the full International Stem Cell cash flow history.

Sign In Create Free Account

About International Stem Cell Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-131723

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License